| Date | Title | Description |
| 24.07.2024 | Edwards Lifesciences Expands Structural Heart Portfolio With Acquisitions of JenaValve and Endotronix | IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today announced investments that reflect the company’s deep commitment to advancing patient care through structural heart innovation, addressing large unmet patient needs and ... |
| 24.06.2024 | Endotronix Receives FDA Premarket Approval of the Cordella™ PA Sensor System for the Treatment of Heart Failure | NAPERVILLE, Ill., June 24, 2024 /PRNewswire/ -- Endotronix, Inc., a privately held company dedicated to advancing the treatment of heart failure (HF) at the intersection of digital health and medtech, today announced Premarket Approval (PMA... |
| 11.10.2023 | Endotronix Receives IDE Approval for the Market Expanding PROACTIVE-HF 2 Clinical Trial. | Naperville, Illinois, USA. 9 October, 2023. Endotronix, Inc., a digital health and medical technology company dedicated to advancing the treatment of heart failure (HF), announced it has received Investigational Device Exemption (IDE) appro... |
| 11.10.2023 | Endotronix Receives IDE Approval for the Market Expanding PROACTIVE-HF 2 Clinical Trial | Endotronix, Inc., a digital health and medical technology company dedicated to advancing the treatment of heart failure (HF), announced it has received Investigational Device Exemption (IDE) approval from the FDA for a subsequent multicente... |
| 06.06.2023 | Endotronix Extends Positive Outcomes with 12-month Data Release from the SIRONA 2 Trial for Remote Heart Failure Management Using the Cordella Pulmonary Artery Sensor. | Lisle, Illinois, USA. 22 May 2023. Seroba’s portfolio company, Endotronix, Inc., a digital health and medical technology company dedicated to advancing the treatment of heart failure (HF), today announced positive 12-month data from the SIR... |
| 05.04.2023 | Endotronix Announces Enrollment Completion of PROACTIVE-HF Pivotal Trial | Endotronix, Inc., a digital health and medical technology company dedicated to advancing the treatment of heart failure (HF), today announced its PROACTIVE-HF pivotal study successfully completed enrollment. Designed to evaluate the safety ... |
| 25.05.2022 | Endotronix Announces Positive Data from SIRONA 2 in Late-Breaking Clinical Trial Session | Lisle, Illinois, USA. 23 May 2022. Endotronix, Inc., a digital health and medical technology company dedicated to advancing the treatment of heart failure (HF), today announced positive data from the SIRONA 2 clinical trial evaluating safet... |
| 27.01.2022 | Endotronix Announces FDA Approval for PROACTIVE-HF Pivotal Trial Design Change to Single-Arm Study. | Lisle, Illinois, USA. 5 January 2022. Seroba portfolio company, Endotronix, Inc., a digital health and medical technology company dedicated to advancing the treatment of heart failure (HF), today announced the U.S. Food and Drug Administrat... |
| 05.01.2022 | Endotronix Announces FDA Approval for PROACTIVE-HF Pivotal Trial Design Change to Single-Arm Study | January 5, 2022 | Press Release |
| 02.03.2021 | Endotronix Appoints Industry Veteran Dan Dearen to Board of Directors | LISLE, IL – MARCH 2, 2021 – Endotronix, Inc., a digital health and medical technology company dedicated to advancing the treatment of heart failure (HF), today announced the appointment of seasoned medical device industry executive Dan Dear... |
| 02.03.2021 | Endotronix Appoints Industry Veteran Dan Dearen to Board of Directors | |
| 19.02.2020 | Endotronix Enrolls First Patients in PROACTIVE-HF Pivotal Trial | LISLE, Ill. /PRNewswire/ — Endotronix, a digital health and medical technology company dedicated to advancing the treatment of chronic heart failure (HF), today announced the enrollment of the first two patients in the PROACTIVE-HF pivotal ... |
| 18.11.2019 | Endotronix Presents Positive Data from the SIRONA First-in-Human Trial for the Cordella™ PA Pressure Sensor System | LISLE, Ill., Nov. 18, 2019 /PRNewswire/ — Endotronix Inc., a digital health and medical technology company dedicated to advancing the treatment of chronic heart failure (HF), presented positive first-in-human data of the Cordella™ Pulmonary... |
| 15.10.2019 | Endotronix Announces Partnership with Tyndall National Institute to Advance Chronic Disease Management | PRNewswire — Endotronix Ireland Limited, a digital health and medical technology company dedicated to advancing the treatment of heart failure (HF), announced today an Enterprise Ireland Industry Partnership project is a collaboration with ... |
| 01.10.2019 | Endotronix Closes Expanded Series D Financing Round of $70 Million for Heart Failure Solution | - |
| 01.10.2019 | Endotronix Closes Expanded Series D Financing Round of $70 Million for Heart Failure Solution | LISLE, IL – Endotronix, Inc., a digital health, medtech company dedicated to advancing the treatment of heart failure (HF), today announced the expansion of its Series D financing round, bringing the total for the round to $70 million. The ... |
| 01.08.2019 | Endotronix Receives conditional IDE approval from the US Food & Drug Administration | Related Article: Endotronix Receives 13485:2016 certification from the British Standards Institution (BSI) for its Quality Management System |
| 16.07.2019 | Endotronix Enrolls First Patient in SIRONA II CE Mark Trial | Study to support European clearance of Cordella™ Pulmonary Artery Sensor System for treatment of patients with chronic heart failure |
| 24.04.2019 | Endotronix Receives ISO 13485:2016 Certification | LISLE, Ill., April 24, 2019 /PRNewswire/ — Endotronix, Inc., a digital health and medical technology company dedicated to advancing the treatment of heart failure, today announced that the company received ISO 13485:2016 certification from ... |
| 03.01.2019 | Endotronix Hires Industry Veteran Jim Yearick as Senior Vice President of Sales and Marketing | LISLE, Ill., Jan. 3, 2019 – Endotronix, Inc., a digital health and medical technology company dedicated to advancing the treatment of heart failure, today announced that industry veteran Jim Yearick has joined the executive leadership team ... |
| 17.09.2018 | For Endotronix, a digital health medtech startup, FDA has dual identities | But what is perhaps more interesting is how the same FDA has reacted to Endotronix’s software product — the Cordella Heart Failure system that the company has recently launched to help cardiology clinics and other providers to manage patien... |
| 14.09.2018 | Endotronix Raises $45 Million in Series D Financing for the Treatment of Heart Failure | - |
| 14.09.2018 | Endotronix Raises $45M in Series D |
LISLE, IL, Endotronix announced the close of a Series D financing round totaling $45 million, led by LSP.
>> Click here for more funding data on Endotronix
>> To export Endotronix funding data to PDF and Excel, click here
... |
| 14.09.2018 | MedTech Startup Endotronix Lands $45M for Heart Failure System | Endotronix, Inc., a digital health, MedTech company dedicated to advancing the treatment of heart failure, today announced it has raised $45 million in Series D funding led by LSP, investing from its LSP Health Economics Fund 2. The round a... |
| 14.09.2018 | Endotronix rakes in $45M for BP sensor implant and digital heart patient tracking | Previous Fierce 15 winner Endotronix raised $45 million to fund development of its Cordella pulmonary artery sensor through CE marking and FDA premarket approval.
Sponsored by Agilent Technologies
How would you like to win free bench space ... |
| 14.09.2018 | Endotronix Raises $45M in Series D Financing | Endotronix, Inc., a Lisle, Ill.-based digital health, medtech company dedicated to advancing the treatment of heart failure, closed a $45m Series D financing round.
The round was led by LSP, investing from its LSP Health Economics Fund 2, a... |
| 14.09.2018 | Endotronix Raises $45 Million in Series D Financing for the Treatment of Heart Failure | Endotronix, Inc., a digital health, medtech company dedicated to advancing the treatment of heart failure, today announced the close of a Series D financing round totaling $45 million. The round was led by LSP, investing from its LSP Health... |
| 14.09.2018 | Remote heart monitoring, management device maker Endotronix lands $45 million | |
| 14.09.2018 | Endotronix rakes in $45M for BP sensor implant and digital heart patient tracking | Previous Fierce 15 winner Endotronix raised $45 million to fund development of its Cordella pulmonary artery sensor through CE marking and FDA premarket approval.
Its platform combines remote patient monitoring software with a wireless, imp... |
| 28.06.2018 | Endotronix Joins American Heart Association’s Center for Health Technology & Innovation to Broaden the Use of Guideline-Based Care for Heart Failure Patients | LISLE, Ill., June 28, 2018 /PRNewswire/ — Endotronix, Inc., a digital health, medtech company dedicated to advancing the treatment of heart failure, today announced they have joined the American Heart Association’s Center for Health Technol... |
| 12.04.2018 | Endotronix Hires Seasoned Life Sciences Executive John Flavin as CFO | LISLE, IL – APRIL 12, 2017- Endotronix, Inc., a medical technology company providing device and digital health solutions for heart failure management, today announced the appointment of seasoned life sciences executive and entrepreneur John... |
| 09.01.2017 | Endotronix Receives $12m Loan from SVB | Endotronix, Inc., a Woodridge, Ill.-based digital health medtech company providing innovative solutions for patients with advanced heart failure, received $12m term loan agreement from Silicon Valley Bank (SVB).
The financing came after a $... |
| 09.01.2017 | New Money: Endotronix Raises $12M From SVB For Its Wireless Heart Monitor | Endotronix
Deal: $12 million in debt financing
Investors: Silicon Valley Bank
What they do: Woodridge, Ill.-based Endotronix is a health tech company that helps patients monitor their heart condition. The company has built an implantable wi... |
| 08.01.2017 | Endotronix gets $12M to further develop remote cardiac monitoring system | Chicago-based Endotronix has added another $12 million in funding to further development on its wireless, remote cardiac monitor system. The money comes in the form a loan agreement with Silicon Valley Bank, and builds on the company’s prev... |
| 29.07.2016 | Digital health companies raised more than $149M in July | During the month of July, MobiHealthNews reported on 16 digital health companies that raised venture funding. The deals total $149.3 million, which is lower on average when compared to other months this year so far but that's expected for t... |
| 17.07.2016 | Endotronix Raises $32M Series C from Aperture Venture Partners | Endotronix, Inc., a digital health medtech company providing innovative solutions for patients with advanced heart failure, announced that the company has closed a $32 million Series C round of financing. The investor syndicate brings toget... |
| 17.07.2016 | Endotronix Raises $32M Series C from BioVentures Investors | Endotronix, Inc., a digital health medtech company providing innovative solutions for patients with advanced heart failure, announced that the company has closed a $32 million Series C round of financing. The investor syndicate brings toget... |
| 16.07.2016 | 5 must-read stories: Pharma’s digital health ambitions, Endotronix raises $32M | Joseph Kim, senior adviser for clinical innovation at Eli Lilly, said he was intrigued by the prospect of using digital health to improve clinical trial recruitment, noting the disappointing figure that only 5 percent of people eligible for... |
| 14.07.2016 | Endotronix Nabs $32M for Wireless Pulmonary Artery Sensor | Endotronix, a digital health startup developing a implantable, wireless pulmonary artery sensor for patients suffering from advanced heart failure has raised $32 million in Series C funding. Participating investors in the round include BioV... |
| 14.07.2016 | Endotronix raises $32M to develop connected implantable heart monitor | Chicago-based Endotronix, which makes devices to manage heart failure and remotely monitor cardiac patients, has raised $32 million in new funding. Investors included BioVentures, SV Life Sciences, Lumira Capital, Aperture Venture Partners ... |
| 14.07.2016 | Endotronix Closes $32 Million in Financing to Address Heart Failure Management | WOODRIDGE, Ill., July 14, 2016 /PRNewswire/ — Endotronix, Inc., a digital health medtech company providing innovative solutions for patients with advanced heart failure, today announced that the company has closed a $32 million Series C rou... |
| 14.07.2016 | Digital Health Medtech Company Endotronix Raises $32m in Series C Funding | Endotronix, Inc., a Woodridge, Ill.-based digital health medtech company, closed a $32m Series C financing.
Backers included BioVentures Investors, SV Life Sciences (SVLS), Lumira Capital, Aperture Venture Partners, and OSF Ventures, existi... |
| 14.07.2016 | Device startup with a digital health twist raises $32M in series C round | Including this round, the company has raised $50 million to date, according to the company’s CEO, Harry Rowland.
Endotronix makes a wireless implantable pulmonary artery pressure sensor for heart failure patients who can be monitored remote... |
| 14.07.2016 | Endotronix Inks $32M Series C Financing |
WOODRIDGE, IL, Endotronix, a digital health medtech company providing innovative solutions for patients with advanced heart failure, today announced that the company has closed a $32 million Series C round of financing.
>> Click he... |
| 12.10.2010 | Heart monitoring firm Endotronix gets $250k JumpStart investment | In July 2008, the company licensed two patents for sensor technology from Cleveland’s NASA Glenn Research Center. The sensors can be implanted in the body, then wirelessly transmit findings to a hand-held or wearable device that transmits t... |
| 12.10.2010 | Endotronix gets $250,000 JumpStart investment | Endotronix Inc., which is developing wireless heart sensor technology licensed from NASA, received a $250,000 investment from JumpStart Ventures.
The funding from the Cleveland-based economic development group is part of a larger, undisclos... |
| - | Heart monitoring firm Endotronix gets $250k JumpStart investment | Endotronix Inc., which is developing wireless heart sensor technology licensed from NASA, has received a $250,000 investment from economic development group JumpStart Ventures.
The funding from JumpStart is part of a larger, undisclosed inv... |
| - | Endotronix Enrolls 1st Patient in SIRONA II CE Mark Trial. | Lisle, Illinois. July 15, 2019. Endotronix, Inc., a digital health and medical technology company dedicated to advancing the treatment of heart failure, today announced enrollment of the first patient in its prospective, multi-center, SIRON... |
| - | 5 must-read stories: Pharma’s digital health ambitions, Endotronix raises $32M | From left: Naomi Fried (moderator), Michael Doherty of Roche, Joseph Kim of Eli Lilly and Dennis Hancock of Pfizer
This week marked our fifth MedCity CONVERGE conference and that’s reflected in our coverage. A panel discussion in which phar... |
| - | FDA Approval for Endotronix Pivotal Trial. | Dublin, Ireland and Lisle, Illinois, USA. August 1, 2019. Seroba’s portfolio company, Endotronix, Inc., a digital health and medical technology company dedicated to advancing the treatment of heart failure (HF), today announced it has recei... |
| - | Endotronix Closes Expanded Series D Round. | Lisle, Illinois & Dublin, Ireland. Oct 1, 2019. Seroba’s investee company, Endotronix, Inc., a digital health, medtech company dedicated to advancing the treatment of heart failure (HF), today announced the expansion of its Series D fin... |
| - | Endotronix Raises $45M Series D Financing. | Ireland and USA. 14 Sept 2018. Endotronix, Inc., a digital health, medtech company dedicated to advancing the treatment of heart failure, today announced the close of a Series D financing round totaling $45 million.
The round was led by LS... |
| - | Endotronix Celebrates 100th Implant Of The Cordella™ Pulmonary Artery Pressure Sensor For Proactive, Remote Management Of Heart Failure | Galway, Ireland and Lisle, IL, USA. March 23, 2021. Endotronix, Inc., a digital health and medical technology company dedicated to advancing the treatment of heart failure, today announced the 100th global implant of the Cordella Pulmonary ... |
| - | For Endotronix, a digital health medtech startup, FDA has dual identities | Endotronix makes the wireless, implantable pulmonary artery pressure sensor to monitor chronic heart failure patients. FDA wants a pivotal trial to tests its effectiveness
Last week Endotronix, a digital health medtech startup based in Lisl... |
| - | Endotronix Announces Partnership with Tyndall National Institute. | Dublin, Ireland. October 15, 2019. Seroba’s portfolio company, Endotronix Ireland Limited, a digital health and medical technology company dedicated to advancing the treatment of heart failure (HF), announced today an Enterprise Ireland Ind... |
| - | Endotronix Appoints Industry Veteran Dan Dearen to Board of Directors. | Lisle, IL, USA. 2 March 2021. Endotronix, Inc., a digital health and medical technology company dedicated to advancing the treatment of heart failure (HF), today announced the appointment of seasoned medical device industry executive Dan De... |
| - | Endotronix Announces Positive Data from the SIRONA First-in-Human Trial for the Cordella™ PA Pressure Sensor System | Lisle, Illinois. November 18, 2019. Seroba’s portfolio company, Endotronix, a digital health and medical technology company dedicated to advancing the treatment of chronic heart failure (HF), presented positive first-in-human data of the Co... |
| - | Device startup with a digital health twist raises $32M in series C round | A medical device company, which leverages digital health and cloud-based tools, announced on Thursday that it has raised $32 million in a series C round.
Endotronix, based in Woodridge, Illinois, raised the money from a syndicate of investo... |
